Close
Select up to 3 companies
Company |
![]()
Verdezyne
|
|
|
|
---|---|---|---|---|
Short Description | Developer of metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of bio-based chemicals using non-food co-products from low cost plant oil feedstocks |
|
|
|
Status | Bankrupt |
|
|
|
Year Founded | 2005 |
|
|
|
Industry Group | materials & chemicals |
|
|
|
Sector | fuels & chemicals |
|
|
|
TRL Range | 7-8 |
|
|
|
Country | United States |
|
|
|
Nbr Employees | 51-100 |
|
|
|
Revenue Range |
|
|
|
|
Total Equity Capital Raised |
$66.4M |
|
|
|
Last Stage Capital Raised |
Growth Equity
round of
$48M
2014 |
|
|
|
Investors | OVP Venture Partners, Monitor Ventures, DSM Venturing, BP Ventures, Tech Coast Angels, Life Science Angels, Sime Darby Berhad, National Institute of Allergy and Infectious Diseases |
|
|
|
Investment Data Information
Investment data is not editable by profile owners.
Please contact research@cleantech.com to make changes.
Close
Hey there!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!


We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!

Startups
Use i3 to gain visibility with corporations and investors looking to invest and partner with external technology companies.

Contact us
Use i3 to access market intelligence on companies, investors, market activity and innovation trends.
Are you involved with a startup or SME looking for strategic partners, investors, or customers? Create your free profile!
Contact us to discuss the full power of i3:
Close
Request Received!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Get in touch
We don't have team members for this company yet!
-
- David Tetzlaf
- Product Manager
-
3 team members on i3
Work at this company?
Claim this profile
Traction
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Back to top